KOREA WHO
-
-
-
CEO of Dong-A Pharmaceutical
Baek Sang-hwan
Professional Manager with Extensive In-House Experience, Focused on Reducing Dependence on Bacchus and Securing New Growth Drivers
-
Last Updated on Nov 5, 2024
-
CEO of Dong-A Pharmaceutical
Life Summary
Baek Sang-hwan is the CEO and President of Dong-A Pharmaceutical.
As a professional manager, he is focused on transforming Dong-A Pharmaceutical into a comprehensive healthcare company.
Born in November 1972, Baek graduated from Korea University with a degree in Western History in 2002.
He joined Dong-A Pharmaceutical in 2000, serving as the head of the Corporate Planning Team and later as the Chief of Corporate Planning. He also held the position of Chief of Corporate Planning at Dong-A Socio Holdings, the parent company.
In 2022, Baek returned to Dong-A Pharmaceutical as CEO and President.
Under his leadership, the company has been expanding its over-the-counter (OTC) business and developing new brands in the health and beauty (H&B) sector. He is also focusing on strengthening the company’s capabilities in the functional household goods sector and boosting cosmetics exports.
Baek has reduced the company's reliance on Bacchus, its flagship product, and established a balanced business structure by positioning premium vitamins like Orthomol as new growth drivers.
#BaekSangHwan #DongAPharmaceutical #HealthcareIndustry #CorporateLeadership #OTCBusiness #HealthAndBeauty #FunctionalProducts #Orthomol #BusinessExpansion #CorporateStrategy
As a professional manager, he is focused on transforming Dong-A Pharmaceutical into a comprehensive healthcare company.
Born in November 1972, Baek graduated from Korea University with a degree in Western History in 2002.
He joined Dong-A Pharmaceutical in 2000, serving as the head of the Corporate Planning Team and later as the Chief of Corporate Planning. He also held the position of Chief of Corporate Planning at Dong-A Socio Holdings, the parent company.
In 2022, Baek returned to Dong-A Pharmaceutical as CEO and President.
Under his leadership, the company has been expanding its over-the-counter (OTC) business and developing new brands in the health and beauty (H&B) sector. He is also focusing on strengthening the company’s capabilities in the functional household goods sector and boosting cosmetics exports.
Baek has reduced the company's reliance on Bacchus, its flagship product, and established a balanced business structure by positioning premium vitamins like Orthomol as new growth drivers.
#BaekSangHwan #DongAPharmaceutical #HealthcareIndustry #CorporateLeadership #OTCBusiness #HealthAndBeauty #FunctionalProducts #Orthomol #BusinessExpansion #CorporateStrategy